2025.06.21本文字数:2900,阅读时长大约7.25分钟导读:自6月17日港股创新药板块回调之际,亚盛医药和科济药业逆势大涨,分别凭借明星产品耐立克®、APG-2575及CAR-T疗法CT071等的突出进展,吸引市场高度关注,彰显创新药行情正从BD驱动转向产品价值驱动,或预示行业新趋势。自6月17日起,港股创新药板块出现回调态势,众多此前备受市场追捧的创新药企业股价跌幅超过5%,港股通...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.